GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
Saved in:
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- GUIDELINES FOR THE USE OF CLOZAPINE IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
- THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
- RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
- A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
- ETHICAL ISSUES OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH INTELLECTUAL DISABILITIES